Adjuvant treatment of post-menopausal women w/ hormone receptor-positive early invasive breast cancer. Adjuvant treatment of early breast cancer in hormone receptor positive post-menopausal women who has received 2-3 yrs of adjuvant tamoxifen. Treatment of advanced breast cancer in post-menopausal women.
Adult including the elderly 1 mg tab once daily. Early disease: Treat for 5 yr. Childn Not recommended. Mild or moderate renal or mild hepatic impairment No dose change recommended.
View Arimidex overdosage for action to be taken in the event of an overdose.
Administration
May be taken with or without food: Swallow whole, do not chew/crush.
Contraindications
Hypersensitivity; pre-menopausal women. Concomitant use w/ oestrogen-containing therapies or tamoxifen therapy. Severe renal impairment; moderate or severe hepatic disease. Pregnancy & lactation.
Osteoporosis; treatment w/ LHRH analogues; reduction in bone mineral density w/ a possible consequent increased risk of fracture. Patients w/ rare hereditary problems of galactose intolerance, the Lapp lactase deficiency or glucose-galactose malabsorption should not take Arimidex. Moderate or severe hepatic impairment, severe renal impairment. Childn.
Sign Out
